ONCOHEROES BIOSCIENCES INC. Press Releases - EIN Presswire

Published on October 13, 2023 - 10:00 GMT

Dovitinib, a potential new treatment for osteosarcoma, receives Orphan Drug Designation from the U.S. FDA

BOSTON, MA, USA, October 13, 2023 /⁨EINPresswire.com⁩/ -- Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation (ODD) to …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on October 2, 2023 - 10:00 GMT

FDA Allows Oncoheroes to Begin Two Pediatric Oncology Clinical Trials

BOSTON, MA, USA, October 2, 2023 /⁨EINPresswire.com⁩/ -- Oncoheroes Biosciences, Inc. (“Oncoheroes”) announced today that the U.S. Food and Drug Administration (FDA) has allowed the Boston-based biotech to proceed with the investigation of two potential …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 23, 2022 - 10:00 GMT

FDA Grants Rare Pediatric Disease Designation (RPDD) to dovitinib for osteosarcoma

BOSTON, MASSACHUSETTS, USA, September 23, 2022 /⁨EINPresswire.com⁩/ -- Oncoheroes Biosciences, Inc. (“Oncoheroes”) is pleased to announce that the United States Food and Drug Administration (FDA) has granted the designation of rare pediatric disease to …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 14, 2022 - 10:00 GMT

Vall d’Hebron Research Institute and Oncoheroes Biosciences Announced a New Partnership in Pediatric Sarcomas

BARCELONA, SPAIN, July 14, 2022 /⁨EINPresswire.com⁩/ -- Vall d’Hebron Research Institute (VHIR), a world-leading healthcare institution where healthcare, research, innovation and education go hand in hand, and Oncoheroes Biosciences, a biotech company …

Distribution channels: Banking, Finance & Investment Industry, Culture, Society & Lifestyle ...

Published on March 17, 2022 - 16:57 GMT

Infinite Love For Kids Fighting Cancer Joins Oncoheroes Biosciences To Bring Hope to Pediatric Cancer Patients

BROOKLINE, MASSACHUSETTS, UNITED STATES, March 17, 2022 /⁨EINPresswire.com⁩/ -- Childhood Cancer is rare and not a single disease, with more than 12 major types of pediatric cancers and over 100 subtypes. Although pediatric cancer death rates have declined …

Distribution channels: Banking, Finance & Investment Industry, Culture, Society & Lifestyle ...

Published on January 3, 2022 - 13:00 GMT

Oncoheroes Biosciences and Allarity Therapeutics Sign Exclusive Pediatric Licensing Agreement for Dovitinib & Stenoparib

BOSTON, MASSACHUSETTS, UNITED STATES, January 3, 2022 /⁨EINPresswire.com⁩/ -- Oncoheroes Biosciences, Inc. (“Oncoheroes”), and Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity”) have signed a worldwide, exclusive pediatric licensing agreement for …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on December 22, 2021 - 20:03 GMT

Oncoheroes Biosciences Receives A Second Investment From Rally Foundation

BOSTON, MASSACHUSETTS, UNITED STATES, December 22, 2021 /⁨EINPresswire.com⁩/ -- In April 2021, Rally Foundation For Childhood Cancer Research invested for the first time in Oncoheroes Biosciences. Today, we are thrilled to announce that Rally Foundation is …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on June 22, 2021 - 16:13 GMT

Oncoheroes Biosciences And Children’s Cancer Research Fund Working Together For A World Without Childhood Cancer

Oncoheroes Biosciences announces the investment of Children’s Cancer Research Fund, a childhood cancer non-profit with a 40 year track record. BOSTON, MASSACHUSETTS, USA, June 22, 2021 /⁨EINPresswire.com⁩/ -- Childhood cancer is still the first cause of …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on April 30, 2021 - 15:08 GMT

Pediatric Cancer Research Foundation joins Oncoheroes Biosciences on their unique approach to defeat childhood cancer

BOSTON, MASSACHUSETTS, UNITED STATES, April 30, 2021 /⁨EINPresswire.com⁩/ -- For close to 40 years, Pediatric Cancer Research Foundation has been pioneering the effort to eliminate childhood cancer by identifying and funding promising leading edge research …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on April 9, 2021 - 14:59 GMT

Rally Foundation Teams Up With Oncoheroes Biosciences On Their Effort Of Bringing New Childhood Cancer Therapies

BOSTON, MASSACHUSETTS, UNITED STATES, April 9, 2021 /⁨EINPresswire.com⁩/ -- Childhood cancer is considered a rare disease affecting 300,000 new families every year worldwide, 90,000 of them unfortunately will lose their loved one. Moreover, more than 95% …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on February 15, 2021 - 21:18 GMT

SHEPHERD Therapeutics and Oncoheroes Biosciences to Partner for the Discovery of Oncology Therapeutics For Rare Cancers

BOSTON, MASSACHUSETTS, UNITED STATES, February 15, 2021 /⁨EINPresswire.com⁩/ -- SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for rare cancer patients, and Oncoheroes Biosciences, a biotech company focused on advancing new …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on October 14, 2020 - 16:27 GMT

Volasertib, a potential new treatment for Rhabdomyosarcoma, receives Orphan Drug Designation from the U.S. FDA

BOSTON, MASSACHUSETTS, UNITED STATES, October 14, 2020 /⁨EINPresswire.com⁩/ -- Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, today announced that the U.S. Food and Drug Administration has granted Orphan Drug …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on September 24, 2020 - 15:39 GMT

FDA Grants Rare Pediatric Disease Designation (RPDD) to Volasertib for Rhabdomyosarcoma

BOSTON, MASSACHUSETTS, UNITED STATES, September 24, 2020 /⁨EINPresswire.com⁩/ -- Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, is pleased to announce that the United States Food and Drug Administration (FDA) has …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on February 10, 2020 - 11:13 GMT

Dreamers Startup Ventures signs an agreement to invest up to $1.1M in Oncoheroes Biosciences

Another endorsement for Oncoheroes Biosciences on their unprecedented effort for advancing new therapies for childhood cancer. BOSTON, MA, USA, February 10, 2020 /⁨EINPresswire.com⁩/ -- Oncoheroes Biosciences Inc. (“Oncoheroes”), a biotech company …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...